Table 1 Characteristics of peripheral blood leukocytes and breast cancer data.
Type | GWAS ID | Trait | Source Institution | Race | Sample size | Year |
|---|---|---|---|---|---|---|
Exposure | ieu-b-29 | Basophil cell count | BCX | European | 563,946 | 2020 |
ieu-b-30 | Leukocyte count | BCX | European | 563,946 | ieu-b-30 | |
ieu-b-31 | Monocyte cell count | BCX | European | 563,946 | 2020 | |
ieu-b-32 | Lymphocyte cell count | BCX | European | 563,946 | 2020 | |
ieu-b-33 | Eosinophil cell count | BCX | European | 563,946 | 2020 | |
ieu-b-34 | Neutrophil cell count | BCX | European | 563,946 | 2020 | |
Outcome | ieu-a-1126 | Breast cancer | BCAC | European | 228,951 | 2017 |
ieu-a-1127 | ER+ Breast cancer | BCAC | European | 175,475 | 2017 | |
ieu-a-1128 | ER− Breast cancer | BCAC | European | 127,442 | 2017 | |
finn-b-C3_BREAST_HER2NEG | HER2− Breast cancer | FinnGen | European | – | 2021 | |
finn-b-C3_BREAST_HERNEG | HER− Breast cancer | FinnGen | European | – | 2021 | |
finn-b-C3_BREAST_HERPLUS | HER+ Breast cancer | FinnGen | European | – | 2021 |
